The EU Drugs Strategy (2013-2020)

Publications

The EU Drugs Strategy (2013-2020)

30 September 2013

A multiannual EU Drugs Strategy (the current one covers the period 2013-2020) sets out the priorities and objectives for the action on drugs of EU countries, the Commission and other EU Institutions and bodies.

The Council endorsed the EU Drugs Strategy (2013-2020) on 7 December 2012. The aim of this strategy is:

  • to contribute to a reduction in drug demand and drug supply within the EU, as well as a reduction as regards the health and social risks and harms caused by drugs.

The Strategy is centred around two pillars: drug demand reduction and drug supply reduction. These are complemented with three cross-cutting themes that represent the horizontal nature of the drugs problem:

  • coordination
  • international cooperation
  • information, research, monitoring and evaluation

Two successive EU Drugs Action Plans, covering the period 2013-2016 and 2017-2020 respectively, set out concrete actions to implement the EU Drugs Strategy: EU Action Plan on Drugs (2013-2016) and the EU Action Plan on Drugs (2017-2020).

Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert.